Novella Clinical, Inc. Company Profile
Novella Clinical, Inc. is a full service contract research organization headquartered in Research Triangle Park, N.C. For more than a decade, Novella has served as an active partner to the oncology, biopharma and medical device industries. As the first global eCRO, Novella integrates deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. For more information, visit www.novellaclinical.com.
News Articles
Novella Clinical Expands West Coast Business Development Team
Novella Clinical, a full service clinical research organization (CRO), today announced two new hires to supplement business development efforts on the west coast. Joining a...
Novella Clinical Resourcing Launches Global Clinical Research Physician Network
Novella Clinical Resourcing, a customized staffing and functional outsourcing services company, has formally launched its
Novella Clinical Names Reg Affairs Director
Kelso brings extensive device experience
Novella Clinical Adds Jon Gockerman, MD as Senior Medical Director for Oncology
Novella Clinical, a full service clinical research organization, today announced Jon P. Gockerman, MD, has joined as senior medical director for oncology within its dedicat...
Novella Clinical Bolsters Business Development with Three New Hires
Novella Clinical, a full service contract research organization (CRO), today announced an expanded business development team with the addition of three Directors of Client...
Byliner Publishes The Castaway: a Novella
By the Critically Acclaimed Frank Huyler "Huyler's writing is quiet, precise, spellbinding from beginning to end … Easily holds with the best contemporary fiction." —The New York Times SAN...
Medtech leaders: Device tax hurts innovation
The U.S. -More- Streamline Combination Product Development This complimentary white paper from Novella Clinical explores combination product regulatory strategies - from classification to m...
LDR closer to FDA approval for cervical disc device
The FDA has issued an approvable letter to LDR for its Mobi-C system, a metal and polyethylene mobile bearing prosthetic devi -More- Streamline Combination Product Development This complimen...
Drugs and Medications
None
PubMed Articles
Molybdenum enzymes are known to underpin key reactions in the biological carbon, nitrogen and sulfur cycles, however, the diversity of these enzymes and the reactions they catalyze especially in bacte...
Treatment of Cu/Zn wastes by combined PSU-electrodeposition processes.
This work is focused on the study of the electrodeposition stage of a combined polymer-supported ultrafiltration (PSU)-electrodeposition process for the recovery and selective separation of Cu/Zn mixt...
This paper describes a highly sensitive electrochemical (voltammetric) determination of sulfite using a combination of Starkeya novella sulfite dehydrogenase (SDH), horse heart cytochrome c (cyt c), a...
This paper provides an interpretation, based on the social systems theory of German sociologist Niklas Luhmann, of the recent paradigmatic shift of mental health care from an asylum-based model to a c...
Effects of creatine in a rat intestinal model of ischemia/reperfusion injury.
PURPOSE: Creatine belongs to a buffering system of cellular ATP level and has been reported to display direct antioxidant activity. Aim of this work was to investigate whether creatine treatment could...
Clinical Trials
The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc....
This is a randomized multicentre trial of emtricitabine (FTC) versus tenofovir (TDF)/FTC in antiretroviral naive subjects with HIV/HBV co-infection over 48 weeks (Clinical Trial A). Plus,...
Clinical Reminders in Test Reports to Improve Guideline Compliance
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Prospective, open-labeled First in Man Clinical Investigation enrolling patients with visually estimated nominal vessel diameter of 3.0 mm receiving a single 3.0 x 12 mm or 3.0 x 18 mm BVS...
The primary objective of this study is to evaluate the broad clinical benefit of dosing Seroquel XR with flexible in the treatment of acute bipolar mania patients with partial response to...
Companies
Novella Clinical, Inc. is a full service contract research organization headquartered in Research Triangle Park, N.C. For more than a decade, Novella has served as an active partn...
Novella Clinical Resourcing, a division of Novella Clinical Inc., provides customized, flexible clinical resourcing services including functional service provider (FSP) relationsh...
Novella Clinical, Inc. is a full service contract research organization headquartered in Research Triangle Park, N.C. For more than a decade, Novella has served as an active partn...
Novella Clinical Inc. & OSI Pharmaceuticals, Inc.
For over a decade, Novella Clinical has been an active partner in supporting the medical device and biopharmaceutical industries with early phase through post-marketing developmen...
Clinical Pathology Laboratory Information Management for Clinical and Pre-Clinical Drug Safety in a Regulatory Environment
More Information about "Novella Clinical, Inc." on BioPortfolio
We have published hundreds of Novella Clinical, Inc. news stories on BioPortfolio along with dozens of Novella Clinical, Inc. Clinical Trials and PubMed Articles about Novella Clinical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novella Clinical, Inc. Companies in our database. You can also find out about relevant Novella Clinical, Inc. Drugs and Medications on this site too.
